Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: A 5-year single-center analysis

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 1, 2015, Pages 21-26

  Huang, Gang ^a   Wang, Chang Xi ^a   Zhang, Lei ^b   Fei, Ji Guang ^a   Deng, Su Xiong ^a   Qiu, Jiang ^a   Li, Jun ^a   Chen, Guo Dong ^a   Fu, Qian ^a   Chen, Li Zhong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Immunosuppression reduction; Infection; Kidney transplantation; Nephrology; Polyomavirus bk

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BK VIRUS; BK VIRUS ALLOGRAFT NEPHROPATHY; BK VIRUS INFECTION; CHINA; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; RENAL GRAFT DYSFUNCTION; TREATMENT OUTCOME; VIRUS REPLICATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; FOLLOW UP; GENETICS; GRAFT RECIPIENT; GRAFT REJECTION; KIDNEY DISEASES; MIDDLE AGED; MORTALITY; PATHOGENICITY; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SURVIVAL; URINE; VIREMIA; VIROLOGY; VIRUS LOAD;

ADULT; BK VIRUS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SURVIVAL ANALYSIS; TACROLIMUS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; URINE; VIRAL LOAD; VIREMIA;

EID: 84916596979     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.09.024     Document Type: Article

References (20)

1. Alméras C., Foulongne V., Garrigue V., Szwarc I., Vetromile F., Segondy M., et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 2008, 85:1099-1104.
2. Almeras C., Vetromile F., Garrigue V., Szwarc I., Foulongne V., Mourad G. Monthly screening for BK-viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis 2011, 13:101-108.
3. Binggeli S., Egli A., Schaub S., Binet I., Mayr M., Steiger J., et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007, 7:1131-1139.
4. Buehrig C.K., Lager D.J., Stegall M.D., Kreps M.A., Kremers W.K., Gloor J.M., et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003, 64:665-673.
5. Comoli P., Binggeli S., Ginevri F., Hirsch H.H. Polyomavirus associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 2006, 8:86-94.
6. Comoli P., Hirsch H.H., Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008, 13:569-574.
7. Drachenberg R.C., Drachenberg C.B., Papadimitriou J.C., Ramos E., Fink J.C., Wali R., et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 2001, 1:373-381.
8. Ginevri F., Azzi A., Hirsch H.H., Basso S., Fontana I., Bodaghi S., et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007, 7:2727-2735.
9. Hardinger K.L., Koch M.J., Bohl D.J., Storch G.A., Brennan D.C. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 2010, 10:407-415.
10. Hirsch H.H., Randhawa P. BK polyomavirus in solid organ transplantation. Am J Transplant 2013, 13(Suppl. 4):179-188. AST Infectious Diseases Community of Practice.
11. Hirsch H.H., Brennan D.C., Drachenberg C.B., Ginevri F., Gordon J., Limaye A.P., et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005, 79:1277-1286.
12. Huang G., Chen L.Z., Qiu J., Wang C.X., Fei J.G., Deng S.X., et al. Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China: a single-center analysis of incidence, reduction in immunosuppression and clinical course. Clinical transplantation 2010, 24:599-609.
13. Huang G., Chen W.-F., Wang C.-X., Fei J.-G., Deng S.-X., Qiu J., et al. Noninvasive tool for the diagnosis of polyomavirus BK associated nephropathy in renal transplant recipients. Diagnostic Microbiology and Infectious Disease 2013, 75:292-297.
14. Lipshutz G.S., Flechner S.M., Govani M.V., Vincenti F. BK nephropathy in kidney transplant recipients treated with a CNI-free immunosuppression regimen. Am J Transplant 2004, 4:2132-2134.
15. Pallet N., Burgard M., Quamouss O., Rabant M., Bererhi L., Martinez F., et al. Cidofovir may be deleterious in BK virus-associated nephropathy. Transplantation 2010, 89:1542-1544.
16. Pappo O., Demetris A.J., Raikow R.B., Randhawa P.S. Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996, 9:105-109.
17. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713-723.
18. Randhawa P.S., Demetris A.J. Nephropathy due to polyomavirus BK. N Engl J Med 2000, 342:1361-1363.
19. Schaub S., Hirsch H.H., Dickenmann M., Steiger J., Mihatsch M.J., Hopfer H., et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus associated nephropathy. Am J Transplant 2010, 10:2615-2623.
20. Sis B., Mengel M., Haas M., Colvin R.B., Halloran P.F., Racusen L.C., et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010, 10:464-471.